Evidence map›Paper›PMID 28652485›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2017

Hepatitis C testing in Canada: don't leave baby boomers behind.

Lianping Ti, Viviane Lima, Mark Hull, Bohdan Nosyk, Jeffrey Joy, Julio Montaner, Mel Krajden, Richard Harrigan, Thomas Kerr, Kate Shannon and 7 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Lianping TiResearch scientists, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Viviane LimaResearch scientists, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Mark HullResearch scientists, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Bohdan NosykResearch scientists, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Jeffrey JoyResearch scientists, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Julio MontanerDirector, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Mel KrajdenMedical Director, Public Health Laboratory, BC Centre for Disease Control, Vancouver, BC.
Richard HarriganDirector, Laboratory Services, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Thomas KerrAssociate Director and Director of Research, BC Centre on Substance Use, Vancouver, BC.
Kate ShannonDirector, Gender Sexual Health Initiative, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.
Evan WoodDirectors, BC Centre on Substance Use, Vancouver, BC.
Jean ShovellerDirectors, BC Centre on Substance Use, Vancouver, BC.
Alnoor RamjiHepatologists, Pacific Gastroenterology Associates, Vancouver, BC.
Hin Hin KoHepatologists, Pacific Gastroenterology Associates, Vancouver, BC.
Eric YoshidaHepatologist, Vancouver General Hospital, Vancouver, BC.
David HallHead, Department of Family and Community Practice, Vancouver Coastal Health, Vancouver, BC.
Rolando BarriosAssistant Director, BC Centre for Excellence in HIV/AIDS, Vancouver, BC.

Funding

Seek and Treat for Optimal Prevention of HIV & AIDS (STOP HIV/AIDS) in BCR01DA036307 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MONTANER, JULIO SERGIO GONZALEZ · 2013 to 2017
$3.0M
NIDA NIH HHS R01 DA036307
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis CCanadaHumans

Identifiers

PMID28652485
PMCPMC5489396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.